High rates of intestinal colonization with carbapenemase producing Enterobacteriaceae in hematopoietic stem cell transplant recipients
Acta Microbiol Immunol Hung. 2024 Feb 21. doi: 10.1556/030.2024.02210. Online ahead of print.ABSTRACTCarbapenem resistant Enterobacteriaceae (CRE) are major human pathogens because, these cause high number of difficult-to-treat infections. Allogeneic hematopoietic stem cell transplant (AHSCT) recipients are highly exposed to these type of bacteria. The aim of our study was to investigate prevalence of CRE colonization in AHSCT patients and to determine genes encoding carbapenem resistance. A retrospective study conducted between January 2015 and December 2019, involved 55 patients colonized with CRE strains. We determined the rate of antibiotic resistance according to European Committee on Antimicrobial Susceptibility Testing (EUCAST) and the carbapenem resistance genes by PCR assays for genes encoding most frequent β-lactamases namely, blaGES, blaKPC, blaIMI, blaNDM, blaVIM, blaIMP and blaOXA-48. Eighty-one episodes of CRE colonization were recorded in 55 patients, mainly suffering from acute leukaemia (30%) and aplastic anemia (26%). History of hospitalization was noted in 80 episodes. Prior antibiotic treatment, severe neutropenia and corticosteroid therapy were respectively found in 94%, 76% and 58% of cases. Among the 55 patients, six patients (11%) developed a CRE infection. The CRE responsible for colonization were carbapenemase producers in 90% of cases. They belonged mostly to Klebsiella pneumoniae (61/81) and Escherichia coli species (10/81). Antibiotic resistance ...
Source: Acta Microbiologica et Immunologica Hungarica - Category: Microbiology Authors: Ikram Ayari Yosra Chebbi Anis Raddaoui Dorra Belloumi Siwar Frigui Rim Werhni Tarek Ben Othmen Nour Abedejlil Wafa Achour Source Type: research
More News: Acute Leukemia | Allergy & Immunology | Anemia | Aplastic Anemia | Cipro | Ciprofloxacin | Corticosteroid Therapy | Gastroenteritis | Genetics | Leukemia | Microbiology | Stem Cell Therapy | Stem Cells | Study | Transplants